Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 186

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

From Stool Transplants to Next-Generation Microbiota Therapeutics

Open access
Petrof, Elaine O., Khoruts, Alexander · 2014 · Gastroenterology

Abstract

The epidemic of Clostridium difficile infection fueled by new virulent strains of the organism has led to increased use of fecal microbiota transplantation (FMT). The procedure is effective for even the most desperate cases, after failure of multiple courses of antibiotics. The approach recognizes microbiota to be integral to normal human physiology, and microbiota being used in FMT represents a new class of therapeutics. Imbalance in the composition and altered activity of the microbiota are associated with many diseases. Consequently, there is growing interest in applying FMT to non-C. difficile indications. However, this may succeed only if microbiota therapeutics are developed systematically, based on mechanistic understanding, and applying updo-date principles of microbial ecology. We discuss two pathways in development of this new therapeutic class: whole microbial communities separated from donor stool and an assembly of specific fecal microorganisms grown in vitro.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2014.01.004

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 64

  1. Blaser, 2009, What are the consequences of the disappearing human microbiota?, Nat Rev Microbiol, 7, 887, 10.1038/nrmicro2245 · DOI · Paper page
  2. Schrezenmeir, 2001, Probiotics, prebiotics, and synbiotics–approaching a definition, Am J Clin Nutr, 73, 361S, 10.1093/ajcn/73.2.361s · DOI · Paper page
  3. de Vrese, 2008, Probiotics, prebiotics, and synbiotics, Adv Biochem Eng Biotechnol, 111, 1
  4. Sanders, 2008, Probiotics: definition, sources, selection, and uses, Clin Infect Dis, 46, S58, 10.1086/523341 · DOI · Paper page
  5. Hoffmann, 2013, Science and regulation. Probiotics: finding the right regulatory balance, Science, 342, 314, 10.1126/science.1244656 · DOI
  6. Borody, 2011, Fecal microbiota transplantation and emerging applications, Nat Rev Gastroenterol Hepatol, 9, 88, 10.1038/nrgastro.2011.244 · DOI · Paper page
  7. Burke, 2013, Fecal transplantation for recurrent Clostridium difficile infection in older adults: a review, J Am Geriatr Soc, 61, 1394, 10.1111/jgs.12378 · DOI
  8. Brandt, 2013, An overview of fecal microbiota transplantation: techniques, indications, and outcomes, Gastrointest Endosc, 78, 240, 10.1016/j.gie.2013.03.1329 · DOI · Paper page
  9. Gough, 2011, Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection, Clin Infect Dis, 53, 994, 10.1093/cid/cir632 · DOI · Paper page
  10. Ley, 2008, Worlds within worlds: evolution of the vertebrate gut microbiota, Nat Rev Microbiol, 6, 776, 10.1038/nrmicro1978 · DOI · Paper page
  11. Hopkins, 1998, Application of 13C NMR to investigate the transformations and biodegradation of organic materials by wood- and soil-feeding termites, and a coprophagous litter-dwelling dipteran larva, Biodegradation, 9, 423, 10.1023/A:1008313309557 · DOI
  12. Guy, 1977, Coprophagy in the African elephant (Loxadonta africana Blumenbach), Afr J Ecol, 15, 174, 10.1111/j.1365-2028.1977.tb00395.x · doi:10.1111/j.1365-2028.1977.tb00395.x
  13. Payne, 2008, Coprophagy by the semi-habituated chimpanzees of Semliki, Uganda, Pan Africa News, 15, 29, 10.5134/143493 · DOI
  14. Jasmin, 2011, Perioperative ruminal pH changes in domestic sheep (Ovis aries) housed in a biomedical research setting, J Am Assoc Lab Anim Sci, 50, 27
  15. McGovern, 2013, Approach to the adult horse with chronic diarrhea, Livestock, 18, 189, 10.12968/live.2013.18.5.189 · doi:10.12968/live.2013.18.5.189
  16. Nurmi, 1973, New aspects of Salmonella infection in broiler production, Nature, 241, 210, 10.1038/241210a0 · DOI · Paper page
  17. Lehrer, 2013, Duodenal infusion of feces for recurrent Clostridium difficile, N Engl J Med, 368, 2144
  18. Eiseman, 1958, Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis, Surgery, 44, 854
  19. Levine, 2006, Vancomycin: a history, Clin Infect Dis, 42, S5, 10.1086/491709 · DOI · Paper page
  20. Tvede, 1989, Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients, Lancet, 1, 1156, 10.1016/S0140-6736(89)92749-9 · DOI · Paper page
  21. Dietrich, 1973, Gnotobiotic care of patients with immunologic deficiency diseases, Transplant Proc, 5, 1271
  22. van der Waaij, 1977, Reconventionalization following antibiotic decontamination in man and animals, Am J Clin Nutr, 30, 1887, 10.1093/ajcn/30.11.1887 · DOI
  23. van der Waaij, 1989, The ecology of the human intestine and its consequences for overgrowth by pathogens such as Clostridium difficile, Annu Rev Microbiol, 43, 69, 10.1146/annurev.micro.43.1.69 · doi:10.1146/annurev.micro.43.1.69
  24. de Vos, 2013, Fame and future of faecal transplantations–developing next-generation therapies with synthetic microbiomes, Microb Biotechnol, 6, 316, 10.1111/1751-7915.12047 · DOI
  25. Ananthakrishnan, 2011, Clostridium difficile infection: epidemiology, risk factors and management, Nat Rev Gastroenterol Hepatol, 8, 17, 10.1038/nrgastro.2010.190 · DOI · Paper page
  26. He, 2013, Emergence and global spread of epidemic healthcare-associated Clostridium difficile, Nat Genet, 45, 109, 10.1038/ng.2478 · DOI · Paper page
  27. Merrigan, 2010, Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production, J Bacteriol, 192, 4904, 10.1128/JB.00445-10 · DOI · Paper page
  28. Eyre, 2013, Diverse sources of C. difficile infection identified on whole-genome sequencing, N Engl J Med, 369, 1195, 10.1056/NEJMoa1216064 · DOI · Paper page
  29. Khanna, 2012, The epidemiology of community-acquired Clostridium difficile infection: a population-based study, Am J Gastroenterol, 107, 89, 10.1038/ajg.2011.398 · DOI · Paper page
  30. Lee, 2013, Community-acquired Clostridium difficile infection: an emerging problem, Curr Emerg Hosp Med Rep, 1, 149, 10.1007/s40138-013-0020-8 · DOI
  31. Hall, 2012, The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007, Clin Infect Dis, 55, 216, 10.1093/cid/cis386 · DOI · Paper page
  32. Jarvis, 2009, National point prevalence of Clostridium difficile in US health care facility inpatients, 2008, Am J Infect Control, 37, 263, 10.1016/j.ajic.2009.01.001 · DOI
  33. Markelov, 2011, Predictors of fatal outcome after colectomy for fulminant Clostridium difficile colitis: a 10-year experience, Am Surg, 77, 977, 10.1177/000313481107700813 · DOI
  34. Lamontagne, 2007, Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain, Ann Surg, 245, 267, 10.1097/01.sla.0000236628.79550.e5 · DOI · Paper page
  35. Silverman, 2010, Success of self-administered home fecal transplantation for chronic Clostridium difficile infection, Clin Gastroenterol Hepatol, 8, 471, 10.1016/j.cgh.2010.01.007 · DOI · Paper page
  36. Bakken, 2011, Treating Clostridium difficile infection with fecal microbiota transplantation, Clin Gastroenterol Hepatol, 9, 1044, 10.1016/j.cgh.2011.08.014 · DOI · Paper page
  37. Bartlett, 2010, Clostridium difficile: progress and challenges, Ann N Y Acad Sci, 1213, 62, 10.1111/j.1749-6632.2010.05863.x · DOI
  38. Stevens, 2011, Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection, Clin Infect Dis, 53, 42, 10.1093/cid/cir301 · DOI · Paper page
  39. Merrigan, 2009, New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administration, Int J Antimicrob Agents, 33, S46, 10.1016/S0924-8579(09)70017-2 · DOI
  40. Banerjee, 2009, Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells, Gut Pathog, 1, 8, 10.1186/1757-4749-1-8 · DOI
  41. Wilson, 1983, Efficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination, J Clin Microbiol, 18, 1017, 10.1128/JCM.18.4.1017-1019.1983 · DOI · Paper page
  42. Francis, 2013, Bile acid recognition by the Clostridium difficile germinant receptor, CspC, is important for establishing infection, PLoS Pathog, 9, e1003356, 10.1371/journal.ppat.1003356 · DOI · Paper page
  43. Giel, 2010, Metabolism of bile salts in mice influences spore germination in Clostridium difficile, PLoS One, 5, e8740, 10.1371/journal.pone.0008740 · DOI · Paper page
  44. Kunimoto, 1986, Recurrent Clostridium difficile-associated colitis responding to cholestyramine, Digestion, 33, 225, 10.1159/000199299 · DOI
  45. Pruksananonda, 1989, Multiple relapses of Clostridium difficile-associated diarrhea responding to an extended course of cholestyramine, Pediatr Infect Dis J, 8, 175
  46. Moncino, 1992, Multiple relapses of Clostridium difficile-associated diarrhea in a cancer patient. Successful control with long-term cholestyramine therapy, Am J Pediatr Hematol Oncol, 14, 361, 10.1097/00043426-199211000-00015 · DOI
  47. Jolley, 2000, Induction of bile acid synthesis by cholesterol and cholestyramine feeding is unimpaired in mice deficient in apolipoprotein AI, Hepatology, 32, 1309, 10.1053/jhep.2000.19811 · DOI
  48. Pantosti, 1985, Comparison of the in vitro activities of teicoplanin and vancomycin against Clostridium difficile and their interactions with cholestyramine, Antimicrob Agents Chemother, 28, 847, 10.1128/AAC.28.6.847 · doi:10.1128/aac.28.6.847
  49. Cohen, 2010, Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA), Infect Control Hosp Epidemiol, 31, 431, 10.1086/651706 · DOI · Paper page
  50. Jarchum, 2012, Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis, Infect Immun, 80, 2989, 10.1128/IAI.00448-12 · DOI
  51. Ryan, 2011, A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins, PLoS Pathog, 7, e1002076, 10.1371/journal.ppat.1002076 · DOI · Paper page
  52. Hung, 2013, Risk factors of fecal toxigenic or non-toxigenic Clostridium difficile colonization: impact of Toll-like receptor polymorphisms and prior antibiotic exposure, PLoS One, 8, e69577, 10.1371/journal.pone.0069577 · doi:10.1371/journal.pone.0069577
  53. Jarchum, 2011, Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis, Infect Immun, 79, 1498, 10.1128/IAI.01196-10 · DOI
  54. Menendez, 2013, Bacterial stimulation of the TLR-MyD88 pathway modulates the homeostatic expression of ileal Paneth cell alpha-defensins, J Innate Immun, 5, 39
  55. Giesemann, 2008, Human alpha-defensins inhibit Clostridium difficile toxin B, Gastroenterology, 134, 2049, 10.1053/j.gastro.2008.03.008 · DOI
  56. Leav, 2010, Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI), Vaccine, 28, 965, 10.1016/j.vaccine.2009.10.144 · DOI · Paper page
  57. Miller, 2012, Guidelines for safe work practices in human and animal medical diagnostic laboratories. Recommendations of a CDC-convened, Biosafety Blue Ribbon Panel, MMWR Surveill Summ, 61, 1
  58. Starkey, 1989, Markers for transfusion-transmitted disease in different groups of blood donors, JAMA, 262, 3452, 10.1001/jama.1989.03430240088036 · DOI
  59. Petrof, 2013, Microbial ecosystems therapeutics: a new paradigm in medicine?, Benef Microbes, 4, 53, 10.3920/BM2012.0039 · DOI
  60. Moore, 1946, Use of sulfasuxidine, streptothricin, and streptomycin in nutritional studies with the chick, J Biol Chem, 165, 437, 10.1016/S0021-9258(17)41154-9 · DOI · Paper page
  61. Jukes, 1953, Nutritional effects of antibiotics, Pharmacol Rev, 5, 381, 10.1016/S0031-6997(25)07332-6 · DOI
  62. Haight, 1955, Effect of prolonged antibiotic administration of the weight of healthy young males, J Nutr, 56, 151
  63. Bennet, 1989, Treatment of ulcerative colitis by implantation of normal colonic flora, Lancet, 1, 164, 10.1016/S0140-6736(89)91183-5 · DOI · Paper page
  64. Borody, 2003, Treatment of ulcerative colitis using fecal bacteriotherapy, J Clin Gastroenterol, 37, 42, 10.1097/00004836-200307000-00012 · DOI · Paper page

Cited by

See all 186

Metadata

Authors
Petrof, E. O., & Khoruts, A.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2014-05
Volume
146
Issue
6
Pages
1573-1582
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2055281532
Cited by
186
References
31
FWCI
11.68
Type
journal article
Language
en
Open access
bronze
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.